Lantern Pharma to Report Second Quarter 2026 Operating & Financial Results on August 14th, 2026 at 9:00 a.m. ET
Webcast to be held Friday, August 14th, 9:00 a.m. ET, register for the webcast here, or at the link provided below.
Lantern Pharma Inc. (NASDAQ: LTRN), an artificial intelligence (“AI”) company developing targeted and transformative cancer therapies using its proprietary RADR® and Open-Medicine AI platforms with multiple clinical stage drug programs, today announced that it will host its second quarter 2026 operating and financial results webcast on Friday, August 14, at 9:00 a.m. Eastern Time / 6:00 a.m. Pacific Time.
Management intends to discuss the operating and financial results for the second quarter ended June 30, 2026 and provide guidance on upcoming milestones, clinical trials and developments relating to the RADR® and Open-Medicine AI platforms. Panna Sharma, President and Chief Executive Officer of Lantern Pharma, will lead the call and will be joined by other members of the management team.
To register for the webinar, please sign up at the Zoom webcast link provided in the link: Lantern Pharma Q2 2026 earnings Zoom webcast registration link. A replay of the earnings call webcast will be available after the call on the investor relations section of the Company's website: ir.lanternpharma.com.
